Immunology & Oncology

Immunology & Oncology November 20, 2024

The Next Frontier in Breast Cancer Prognostics: Artificial Intelligence Revolutionizing Tumor-Infiltrating Lymphocytes Assessment

Tumor-infiltrating lymphocytes are biomarkers of the tumor microenvironment’s dynamics and a patient’s intrinsic anti-tumor immunity.

Immunology & Oncology November 18, 2024

Shape Matters: Studying Cancer Invasion through 3D Tumoroids and Organoids

By bridging the gap between traditional 2D cultures and the complexities of in vivo tumors, ReSCUE provides a powerful tool to unravel the intricacies of cancer biology.

Immunology & Oncology November 11, 2024

The Rhythm of Immunity: How Our Internal Clock Regulates Immune Responses and Metabolism

As our understanding of circadian biology deepens, so too does the potential for circadian-based therapies that restore natural immune and metabolic rhythms.

Immunology & Oncology October 31, 2024

Plasma Cell Leukemia: A Complex Journey from Multiple Myeloma

Given the rarity and aggressiveness of PCL, therapeutic advances will depend on prospective studies examining these cytogenetic markers.

Immunology & Oncology October 29, 2024

Decoding Systemic Sclerosis: The Intricate Web of Immune Mechanisms and Treatment Frontiers

A deeper molecular understanding of systemic sclerosis will likely usher in tailored treatment strategies, potentially combining multiple targeted therapies to address immune abnormalities.

Immunology & Oncology October 25, 2024

miRNA Therapeutics: Bridging the Gap Between Cancer and Neurological Disorders

miRNA therapeutics are in the early stages of development but show significant promise for the treatment of neurological disorders.

Immunology & Oncology October 23, 2024

Understanding Prostate Cancer: The Roles of Chronic Inflammation, Diagnostic Biomarkers, and Lifestyle Modifications

The future of PCa diagnostics lies in the continued refinement of molecular biomarkers and imaging technologies.

Immunology & Oncology October 9, 2024

A New Era in Immunotherapy: Challenges and Potential in Acute Myeloid Leukemia Treatment

Among the promising modern approaches for AML is chimeric antigen receptor (CAR) T cell therapy.

Immunology & Oncology July 30, 2024

Silent Killer: Understanding the Enigma of Pancreatic Ductal Adenocarcinoma

The CAM model represents a significant advancement in cancer research, offering a unique platform for studying tumor growth, perfusion, and metastasis.

Immunology & Oncology March 15, 2024

Forging a Hopeful Outlook on Cancer Drug Development

The core of oncotherapy is still about reducing human suffering and facing the many challenges of this disease together.

Immunology & Oncology February 13, 2024

Patterns, Profiles, and Patient Outcomes: AI in Oncotherapeutics

AI presents a beacon of hope in revolutionizing cancer management across various stages.

Immunology & Oncology January 10, 2024

Novartis’ Strategic Acquisition of Calypso: A Game-Changer in Autoimmune Therapies

IL-15 therapeutics trailblazer Calypso announces a deal to be acquired by Novartis.

Immunology & Oncology January 8, 2024

Interleukin-15 and Its Diversified Roles in Inflammation, Infection and Immune Reaction

Interleukin-15 (IL-15) is a versatile cytokine, exhibiting a wide array of biological functions across various cell types.

Immunology & Oncology November 29, 2023

AIP Charts a Transformative Course as Nuclear Medicine Gains Traction

Headed by Rose Satz, AIP aims to maximize the clinical impact of nuclear medicine.

Immunology & Oncology November 15, 2023

AIP Revolutionizes Oncotherapeutics with Peptide Receptor Radionuclide Therapy

AIP spearheads groundbreaking research in peptide receptor radionuclide therapeutics (PRRT).

Immunology & Oncology July 14, 2023

Immune Reconstitution Part 10: The Future of Immunology

Part 10 of Immune Reconstitution Article Series.

Immunology & Oncology July 14, 2023

Immune Reconstitution Part 9: The Hope of CGT in Boosting the Immune System

Part 9 of Immune Reconstitution Article Series.

Immunology & Oncology July 13, 2023

Immune Reconstitution Part 8: Immunotherapy for Malignancy

Part 8 of Immune Reconstitution Article Series.